Eventide Asset Management’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Eventide Asset Management’s Portfolio SGMO Stock Details SGMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-482,500	Closed	-$2.72M	–	141
2015 Q3	$2.72M	Hold	482,500	–	–	0.16%	91
2015 Q2	$5.35M	Hold	482,500	–	–	0.29%	73
2015 Q1	$7.57M	Hold	482,500	–	–	0.57%	62
2014 Q4	$7.34M	Hold	482,500	–	–	0.8%	57
2014 Q3	$5.2M	Hold	482,500	–	–	0.73%	56
2014 Q2	$7.37M	Buy	482,500 +20,000	+4%	+$288K	1%	49
2014 Q1	$8.36M	Buy	462,500 +245,200	+113%	+$4.73M	1.3%	37
2013 Q4	$3.02M	Buy	+217,300	New	+$2.5M	0.93%	48

Other funds holding SGMO

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

EAM

EverPoint Asset Management Stamford, Connecticut $5.38B AUM 21.45% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Eventide Asset Management's SGMO Position: Q4 2015 in Review

Eventide Asset Management sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q4 2015, closing a stake of 482,500 shares — an estimated $2.72M sold.

Eventide Asset Management first reported a position in SGMO in Q4 2013 and held it in 8 quarters. The position peaked at $8.36M in Q1 2014. 141 funds tracked by Wall St. Rank hold SGMO as of Q4 2015.

Eventide Asset Management reported no remaining SANGAMO THERAPEUTICS INC position as of Q4 2015 after selling out during the quarter.
Eventide Asset Management sold 482,500 SANGAMO THERAPEUTICS INC shares in Q4 2015, an estimated $2.72M.
Eventide Asset Management first reported a position in SANGAMO THERAPEUTICS INC in Q4 2013 and held it in 8 quarters.
Eventide Asset Management's SANGAMO THERAPEUTICS INC position peaked at $8.36M in Q1 2014.
141 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q4 2015.

Based on Eventide Asset Management's 13F filing for Q4 2015, filed 16 Feb 2016.